Silo Pharma, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Silo Pharma, Inc. now
Current reporting with the operating signal separated from the noise.
Silo Pharma, Inc.: Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
The story matters when it changes Silo Pharma, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Silo Pharma, Inc. Approves $1 Million Bitcoin Purchase as Treasury Reserve Asset
The story matters when it changes Silo Pharma, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Silo Pharma, Inc. Advances Development of SPC-15 and SP-26 with IND Submission Expected in 2025
The story matters when it changes Silo Pharma, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest SILO filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Silo Pharma, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →